Zobrazeno 1 - 10
of 214
pro vyhledávání: '"Gunnar H, Heine"'
Autor:
Julia T. Stadler, Thomas Bärnthaler, Andrea Borenich, Insa E. Emrich, Hansjörg Habisch, Alankrita Rani, Michael Holzer, Tobias Madl, Gunnar H. Heine, Gunther Marsche
Publikováno v:
Journal of Lipid Research, Vol 65, Iss 9, Pp 100624- (2024)
Chronic kidney disease (CKD) is often associated with decreased activity of lecithin-cholesterol acyltransferase (LCAT), an enzyme essential for HDL maturation. This reduction in LCAT activity may potentially contribute to an increased risk of cardio
Externí odkaz:
https://doaj.org/article/5c3ea07d13764db9a37485baff1a6bba
Autor:
Insa E. Emrich, Gunnar H. Heine, P. Christian Schulze, Kyrill S. Rogacev, Danilo Fliser, Stefan Wagenpfeil, Michael Böhm, Dieter Lütjohann, Oliver Weingärtner
Publikováno v:
Pharmacology Research & Perspectives, Vol 9, Iss 4, Pp n/a-n/a (2021)
Abstract In dialysis patients, cholesterol‐lowering therapy with statins is less effective than in other high‐risk patients. This may be explained by a shift from cholesterol synthesis toward cholesterol absorption. In line, markers of cholestero
Externí odkaz:
https://doaj.org/article/f228083a5aac4c9694e0f10876973365
Autor:
Patrick B Mark, Juan J Carrero, Kunihiro Matsushita, Yingying Sang, Shoshana H Ballew, Morgan E Grams, Josef Coresh, Aditya Surapaneni, Nigel J Brunskill, John Chalmers, Lili Chan, Alex R Chang, Rajkumar Chinnadurai, Gabriel Chodick, Massimo Cirillo, Dick de Zeeuw, Marie Evans, Amit X Garg, Orlando M Gutierrez, Hiddo J L Heerspink, Gunnar H Heine, William G Herrington, Junichi Ishigami, Florian Kronenberg, Jun Young Lee, Adeera Levin, Rupert W Major, Angharad Marks, Girish N Nadkarni, David M J Naimark, Christoph Nowak, Mahboob Rahman, Charumathi Sabanayagam, Mark Sarnak, Simon Sawhney, Markus P Schneider, Varda Shalev, Jung-Im Shin, Moneeza K Siddiqui, Nikita Stempniewicz, Keiichi Sumida, José M Valdivielso, Jan van den Brand, Angela Yee-Moon Wang, David C Wheeler, Lihua Zhang, Frank L J Visseren, Benedicte Stengel
Publikováno v:
European Heart Journal. 44(13):1157-1166
Aims Chronic kidney disease (CKD) increases risk of cardiovascular disease (CVD). Less is known about how CVD associates with future risk of kidney failure with replacement therapy (KFRT). Methods and results The study included 25 903 761 individuals
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b1c5b508c0b05035b1feed37e73661b
https://hdl.handle.net/11370/3aa20e49-9483-407e-b68e-a14656ea1fb3
https://hdl.handle.net/11370/3aa20e49-9483-407e-b68e-a14656ea1fb3
Autor:
Kathrin Untersteller, Sabine Meissl, Markus Trieb, Insa E. Emrich, Adam M. Zawada, Michael Holzer, Eva Knuplez, Danilo Fliser, Gunnar H. Heine, Gunther Marsche
Publikováno v:
Journal of Lipid Research, Vol 59, Iss 7, Pp 1256-1265 (2018)
CVD remains the leading cause of morbidity and mortality in patients with chronic kidney disease (CKD). CKD profoundly affects HDL composition and functionality, but whether abnormal HDL independently contributes to cardiovascular events in CKD patie
Externí odkaz:
https://doaj.org/article/2eaa44406f62425dbee57515518bd23f
Publikováno v:
Biomolecules, Vol 10, Iss 9, p 1348 (2020)
In the general population, the ability of high-density lipoproteins (HDLs) to promote cholesterol efflux is a predictor of cardiovascular events, independently of HDL cholesterol levels. Although patients with chronic kidney disease (CKD) have a high
Externí odkaz:
https://doaj.org/article/4d4bb880079149ae842d9256f2944c1e
Publikováno v:
Frontiers in Endocrinology, Vol 9 (2018)
Externí odkaz:
https://doaj.org/article/9471c1af08724e718228ad0c0cbd50c0
Publikováno v:
Frontiers in Endocrinology, Vol 9 (2018)
Fibroblast growth factor−23 (FGF23) is a mainly osteocytic hormone which increases renal phosphate excretion and reduces calcitriol synthesis. These renal actions are mediated via alpha-klotho as the obligate co-receptor. Beyond these canonical “
Externí odkaz:
https://doaj.org/article/bb7ac91eafc14f24bbd960245b3e9cd1
Autor:
Gunnar H. Heine, Kyrill S. Rogacev, Insa E. Emrich, Felix Mahfoud, Michael Böhm, Stefan Wagenpfeil, Stephan H. Schirmer, Danilo Fliser, Anja L. Scheuer
Publikováno v:
Clinical Kidney Journal. 15:693-702
Background Since kidney transplant recipients (KTRs) have a high cardiovascular disease burden, adequate risk prediction is of importance. Whether echocardiographic parameters and plasma biomarkers, natriuretic peptides [N-terminal pro-B-type natriur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::705ffe546e4602c63a0c99a8007d4758
https://doi.org/10.1093/ckj/sfab216
https://doi.org/10.1093/ckj/sfab216
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 146:742-746
Was ist neu? Sekundäre Hypertonie 2016 wurden Handlungsempfehlungen zum primären Hyperaldosteronismus in einer internationalen Leitlinie veröffentlicht, die 2018 speziell aus europäischer Sicht erweitert wurden. Ziel ist es, frühzeitig die entsp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd7f89ed71b9e27817ac315b728f3e6c
https://doi.org/10.1055/a-1262-5777
https://doi.org/10.1055/a-1262-5777
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 146:518-524
Understanding the (patho-)physiology of volume regulation and osmoregulation is fundamental to guide patient advice and therapy in chronic kidney disease (CKD). Volume regulation primarily impacts the amount of sodium in the body, and it mainly affec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad91e1d4a95f9ae2a30803b7e8025b3b
https://doi.org/10.1055/a-1267-5219
https://doi.org/10.1055/a-1267-5219